Other
Other Noncash Income (Expense)
Thermo Fisher Scientific Other Noncash Income (Expense) increased by 37.1% to -$88.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 34.8%, from -$135.00M to -$88.00M. Over 3 years (FY 2022 to FY 2025), Other Noncash Income (Expense) shows an upward trend with a -6.1% CAGR.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
Metric ID:
other_other_noncash_income_expenseHistorical Data
18 periods
| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$144.00M | -$233.00M | -$58.00M | -$152.00M | -$107.00M | -$181.00M | -$149.00M | -$111.00M | -$163.00M | -$53.00M | -$104.00M | -$97.00M | -$254.00M | -$135.00M | -$63.00M | -$117.00M | -$140.00M | -$88.00M |
| QoQ Change | — | -61.8% | +75.1% | -162.1% | +29.6% | -69.2% | +17.7% | +25.5% | -46.8% | +67.5% | -96.2% | +6.7% | -161.9% | +46.9% | +53.3% | -85.7% | -19.7% | +37.1% |
| YoY Change | — | — | +59.7% | — | — | +22.3% | -156.9% | +27.0% | -52.3% | +70.7% | +30.2% | +12.6% | -55.8% | -154.7% | +39.4% | -20.6% | +44.9% | +34.8% |
Range-$254.00M – -$53.00M
CAGR-10.9%
Avg YoY Growth-7.1%
Median YoY Growth+24.6%
Other Noncash Income (Expense) at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's other noncash income (expense)?
- Thermo Fisher Scientific (TMO) reported other noncash income (expense) of -$88.00M in Q1 2026.
- How has Thermo Fisher Scientific's other noncash income (expense) changed year-over-year?
- Thermo Fisher Scientific's other noncash income (expense) increased by 34.8% year-over-year, from -$135.00M to -$88.00M.
- What is the long-term trend for Thermo Fisher Scientific's other noncash income (expense)?
- Over 3 years (2022 to 2025), Thermo Fisher Scientific's other noncash income (expense) has grown at a -6.1% compound annual growth rate (CAGR), from -$550.00M to -$455.00M.